![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmacology, Medical College of Ohio, Toledo, Ohio
Abstract
Because beneficial effects of digitalis treatment in breast cancer patients have been suggested by epidemiological studies, we explored the mechanism of the growth inhibitory effects of these drugs on the estrogen receptor-negative human breast cancer cell line MDA-MB-435s. Ouabain concentrations (100 nM or lower) that caused less than 25% inhibition of the pumping function of Na+/K+-ATPase had no effect on cell viability but inhibited proliferation. At the same concentrations, ouabain 1) activated Src kinase and stimulated the interaction of Src and Na+/K+-ATPase with epidermal growth factor receptor (EGFR); 2) caused a transient and then a sustained activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2); 3) increased the expression of p21Cip1 but decreased that of p53; and 4) activated c-Jun NH2-terminal kinase (JNK) but not p38 kinase. These data, in conjunction with our previous findings on the signaling role of Na+/K+-ATPase in other cells, suggest that ouabain-induced activation/transactivation of Src/EGFR by Na+/K+-ATPase leads to activation of ERK1/2, the resulting increase in the level of cell cycle inhibitor p21Cip1, and growth arrest. Cooperation of JNK with ERK1/2 in this process is also suggested. Digoxin and digitoxin concentrations close to or at the therapeutic plasma levels had effects on proliferation and ERK1/2 similar to those of ouabain, supporting the proposed potential value of digitalis drugs for the treatment of breast cancer.
Address correspondence to: Dr. Amir Askari, Department of Pharmacology, Medical College of Ohio, 3035 Arlington Ave., Toledo, OH 43614-5804. E-mail: mheck{at}mco.edu
This article has been cited by other articles:
|
|
 |
|
  I. Prassas, M. Paliouras, A. Datti, and E. P. Diamandis High-Throughput Screening Identifies Cardiac Glycosides as Potent Inhibitors of Human Tissue Kallikrein Expression: Implications for Cancer Therapies Clin. Cancer Res., September 15, 2008; 14(18): 5778 - 5784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Zavareh, K. S. Lau, R. Hurren, A. Datti, D. J. Ashline, M. Gronda, P. Cheung, C. D. Simpson, W. Liu, A. R. Wasylishen, et al. Inhibition of the Sodium/Potassium ATPase Impairs N-Glycan Expression and Function Cancer Res., August 15, 2008; 68(16): 6688 - 6697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujii, Y. Takahashi, Y. Itomi, K. Fujita, M. Morii, Y. Tabuchi, S. Asano, K. Tsukada, N. Takeguchi, and H. Sakai K+-Cl- Cotransporter-3a Up-regulates Na+,K+-ATPase in Lipid Rafts of Gastric Luminal Parietal Cells J. Biol. Chem., March 14, 2008; 283(11): 6869 - 6877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Newman, P. Yang, A. D. Pawlus, and K. I. Block Cardiac Glycosides as Novel Cancer Therapeutic Agents Mol. Interv., February 1, 2008; 8(1): 36 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Stahli, A. Breitenstein, A. Akhmedov, G. G. Camici, K. Shojaati, N. Bogdanov, J. Steffel, D. Ringli, T. F. Luscher, and F. C. Tanner Cardiac Glycosides Regulate Endothelial Tissue Factor Expression in Culture Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2769 - 2776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu, X. Zhao, S. V. Pierre, and A. Askari Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1489 - C1497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ihenetu, H. M. Qazzaz, F. Crespo, R. Fernandez-Botran, and R. Valdes Jr Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia Clin. Chem., July 1, 2007; 53(7): 1315 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Liang, J. Tian, L. Liu, S. Pierre, J. Liu, J. Shapiro, and Z.-J. Xie Identification of a Pool of Non-pumping Na/K-ATPase J. Biol. Chem., April 6, 2007; 282(14): 10585 - 10593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, B. A. Wible, X. Wan, and E. Ficker Cardiac Glycosides as Novel Inhibitors of Human Ether-a-go-go-Related Gene Channel Trafficking J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kotova, L. Al-Khalili, S. Talia, C. Hooke, O. V. Fedorova, A. Y. Bagrov, and A. V. Chibalin Cardiotonic Steroids Stimulate Glycogen Synthesis in Human Skeletal Muscle Cells via a Src- and ERK1/2-dependent Mechanism J. Biol. Chem., July 21, 2006; 281(29): 20085 - 20094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, S. Zelenin, A. Aperia, and O. Aizman Low Doses of Ouabain Protect from Serum Deprivation-Triggered Apoptosis and Stimulate Kidney Cell Proliferation via Activation of NF-{kappa}B J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1848 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Palmer The 59th Symposium of the Society of General Physiologists Na,K-ATPase and Related Cation Pumps: Structures, Mechanisms, and Diseases J. Gen. Physiol., January 30, 2006; 127(2): 77 - 87. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Langenhan, N. R. Peters, I. A. Guzei, F. M. Hoffmann, and J. S. Thorson Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization PNAS, August 30, 2005; 102(35): 12305 - 12310. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
